Chembio Diagnostics (CEMI)

Chembio Diagnostics Stock Analysis & Ratings

CEMI Stock Chart & Stats

Day’s Range$0.58 - $0.6386
52-Week Range$0.42 - $7.34
Previous Close$0.63
Average Volume (3M)310.94K
Market Cap$18.77M
P/E Ratio-0.4
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A
EPS (TTM)-1.44



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Chembio Diagnostics’s price range in the past 12 months?
Chembio Diagnostics lowest stock price was $0.41 and its highest was $7.34 in the past 12 months.
    What is Chembio Diagnostics’s market cap?
    Chembio Diagnostics’s market cap is $18.77M.
      What is Chembio Diagnostics’s price target?
      Currently, no data Available
      What do analysts say about Chembio Diagnostics?
      Chembio Diagnostics’s analyst rating consensus is a ‘Hold. This is based on the ratings of 1 Wall Streets Analysts.
        When is Chembio Diagnostics’s upcoming earnings report date?
        Chembio Diagnostics’s upcoming earnings report date is Aug 10, 2022 which is in 77 days.
          How were Chembio Diagnostics’s earnings last quarter?
          Chembio Diagnostics released its earnings results on May 05, 2022. The company reported -$0.29 earnings per share for the quarter, missing the consensus estimate of -$0.21 by -$0.08.
            Is Chembio Diagnostics overvalued?
            According to Wall Street analysts Chembio Diagnostics’s price is currently Overvalued.
              Does Chembio Diagnostics pay dividends?
              Chembio Diagnostics does not currently pay dividends.
              What is Chembio Diagnostics’s EPS estimate?
              Chembio Diagnostics’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Chembio Diagnostics have?
              Chembio Diagnostics has 30,220,000 shares outstanding.
                What happened to Chembio Diagnostics’s price movement after its last earnings report?
                Chembio Diagnostics reported an EPS of -$0.29 in its last earnings report, missing expectations of -$0.21. Following the earnings report the stock price went down -16.418%.
                  Which hedge fund is a major shareholder of Chembio Diagnostics?
                  Among the largest hedge funds holding Chembio Diagnostics’s share is Royce & Associates LLC. It holds Chembio Diagnostics’s shares valued at 111K.


                    Chembio Diagnostics Stock Analysis

                    Smart Score
                    Not Ranked
                    Price Target
                    No data currently available
                    This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Chembio Diagnostics

                    Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Medford, NY.

                    Similar Stocks
                    Price & Change
                    Orasure Technologies
                    Bio-Rad Laboratories
                    Riot Blockchain
                    Trinity Biotech

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis